Eastling Thomas Wilson (CIK 1958487) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-04-18). Recent activity: Buy GYRE (15,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-18 | GYRE THERAPEUTICS, INC. (GYRE) | Director | Buy | 15,000 | $103,950 |
来源：SEC Form 4 申报文件 · 截至 2025-04-18